ask our doctors

Lymphoma Follicular

Get the facts on Lymphoma Follicular treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Lymphoma Follicular prevention, screening, research, statistics and other Lymphoma Follicular related topics. We answer all your qestions about Lymphoma Follicular.

Question: In follicular lymphoma do they egver remove lymph nodes? I have stage 4 follicular lymphoma and I was wondering do they ever remove nodes or is this not a good Idea. Also is stem cell replacement a option. I \have heard it has been done in other non hodgens lymphoma.

Answer: As a general rule, the only reason lymph nodes are removed in lymphoma patients is for biopsy. Lymphoma is considered a blood cancer, which means it is presumed to be circulating throughout the body, so removing lymph nodes won't really treat lymphoma. To learn more about your treatment options ... first, I would recommend checking out the Leukemia and Lymphoma Society ... it offers free patient help on things like treatment options, where to find doctors, trials, etc. They have people available 10 AM to 5 PM eastern time. Go here: http://www.lls.org/hm_lls and click on live patient help up at the top of the page. LLS is also a good place to do research. For general information these are good links to get you started: http://www.lymphomation.org/type-follicu… http://www.lymphomainfo.net/nhl/follicul… http://www.nhlcyberfamily.org/types/foll… This is also an excellent PDF from the American Cancer Society on Non-Hodgkin's Lymphoma (it is a big file will take a few seconds to download even on a fast connection): http://www.cancer.org/downloads/CRI/F952… That document outlines treatment options for different kinds of N-HL including follicular lymphoma. Use the index ... the follicular lymphoma info starts around page 35. Stem cell transplant is at least listed there as a possible option. You may also want to try and connect with other patients; I am almost certain you will find patients with follicular lymphoma on this forum in the Non-Hodgkin's area: http://forums.lymphoma.com/ Best of luck to you.


Lymphoma Follicular News

Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN(R) in Combination ...

MarketWatch (press release)
ZEVALIN (ibritumomab tiuxetan) injection for intravenous use, is indicated for the treatment of patients with relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL). ZEVALIN is also indicated for the treatment of patients ...
 

Biovest makes a move on the EU market with BiovaxID

FierceVaccines
Biovest International's ($BVTI) stock has risen by 15% on two pieces of news about its personalized cancer vaccine for the treatment of follicular non-Hodgkin lymphoma, BiovaxID. The company will seek marketing approval in the EU for the vaccine, ...
 

Spectrum Pharma begins Phase 2 study Of ZEVALIN Injection - quick facts

RTT News
... announced the initiation of a Phase 2 study evaluating ZEVALIN Injection for intravenous use + rituximab in combination with motexafin gadolinium or MGd in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma.
 

Biovest to Seek Marketing Approval in the EU for BiovaxID(R) Personalized ...

MarketWatch (press release)
The EU market has an estimated 23000 patients diagnosed with follicular lymphoma each year which is roughly equal in size to the US market. We believe that with approval, patients and physicians will embrace BiovaxID as being a safe and effective ...
 

Identifying Appropriate Patient Groups and Drug Targets in DLBCL

Cancer Network
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma. J Clin Oncol. 2009;27:3036-43. 5. Levy R, Robertson MJ, ...
 

Clinical Oncology News

CHOP-RIT, CHOP-R Similar for Follicular Lymphomas
Clinical Oncology News
 

Biovest Retains Ferghana Partners to Evaluate Strategic Transactions

MarketWatch (press release)
Moreover, BiovaxID provides substantial and durable clinical efficacy with the Phase III clinical trial demonstrating that BiovaxID significantly improves disease-free survival in follicular lymphoma and the Phase II mantle cell lymphoma clinical trial ...
 

TG Therapeutics, Inc. Announces Investigational New Drug (IND) for TGTX-1101 ...

MarketWatch (press release)
Once the optimal dose is determined, up to 77 patients will be enrolled and stratified by subtype of B-cell Lymphoma, including Follicular Lymphoma, Diffuse Large B-Cell Lymphoma and other NHL subtypes for the Phase II component.
 

UPDATE: Cancer Genetics Plans $48.6M IPO

GenomeWeb
The company added that it is validating its MatBA microarray technology for other lymphoma subtypes, including mantle-cell lymphoma, follicular lymphoma, and diffuse large B cell lymphoma. Cancer Genetics also is developing another microarray ...
 

Clinical Oncology News

New Antibody Promising for Relapsed Lymphoma
Clinical Oncology News